Mereo BioPharma Group plc (MREO) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts MREO Hot Sheet
Price: $0.29 +7.41%
Financial Fact:
Gross profit (loss): 21.36K
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
Gross profit (loss): 21.36K
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Mereo BioPharma Group plc (NASDAQ: MREO) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02).
For earnings history and earnings-related data on Mereo BioPharma Group plc (MREO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Disney names Adam Smith chairman of direct-to-consumer unit
- StrategX closes second tranche, raising $198,000 in private placement
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
